The
loss of proteostasis over the life course is associated with
a wide range of debilitating degenerative diseases and is a central
hallmark of human aging. When left unchecked, proteins that are intrinsically
disordered can pathologically aggregate into highly ordered fibrils,
plaques, and tangles (termed amyloids), which are associated with
countless disorders such as Alzheimer’s disease, Parkinson’s
disease, type II diabetes, cancer, and even certain viral infections.
However, despite significant advances in protein folding and solution
biophysics techniques, determining the molecular cause of these conditions
in humans has remained elusive. This has been due, in part, to recent
discoveries showing that soluble protein oligomers, not insoluble
fibrils or plaques, drive the majority of pathological processes.
This has subsequently led researchers to focus instead on heterogeneous
and often promiscuous protein oligomers. Unfortunately, significant
gaps remain in how to prepare, model, experimentally corroborate,
and extract amyloid oligomers relevant to human disease in a systematic
manner. This Review will report on each of these techniques and their
successes and shortcomings in an attempt to standardize comparisons
between protein oligomers across disciplines, especially in the context
of neurodegeneration. By standardizing multiple techniques and identifying
their common overlap, a clearer picture of the soluble neuropathological
aggresome can be constructed and used as a baseline for studying human
disease and aging.